Skip to Main Content

Paper Details

Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.
3
2023
AZD7442, B-cell malignancies, SARS-CoV, patients
Author NameAffiliation
Lilin LaiEmory University School of Medicine
Lilin LaiEmory University School of Medicine
Lilin LaiEmory National Primate Research Center
Mehul S SutharEmory University School of Medicine
Mehul S SutharEmory University School of Medicine
Rafi AhmedEmory University School of Medicine
  • 1 - 6

Datasets

Release 1.2